Found: 22
Select item for more details and to access through your institution.
Reply to "Assessing the impacts of integrative therapies on pain and anxiety after gynecological oncology surgery".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1941, doi. 10.1002/cncr.34803
- By:
- Publication type:
- Article
New standard of care for refractory metastatic colorectal cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1789, doi. 10.1002/cncr.34840
- By:
- Publication type:
- Article
Nonopioid alternatives after major abdominopelvic cancer surgery.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1790, doi. 10.1002/cncr.34841
- By:
- Publication type:
- Article
Targeted therapy for lung cancer: Beyond EGFR and ALK.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1803, doi. 10.1002/cncr.34757
- By:
- Publication type:
- Article
First person profile: Mary‐Ellen Taplin, MD: Dr Taplin's history in genitourinary cancer research and her focus on offering excellent clinical care has made her a favorite among researchers and patients alike.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1788, doi. 10.1002/cncr.34839
- By:
- Publication type:
- Article
Assessing the impacts of integrative therapies on pain and anxiety after gynecological oncology surgery.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1939, doi. 10.1002/cncr.34805
- By:
- Publication type:
- Article
Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1836, doi. 10.1002/cncr.34750
- By:
- Publication type:
- Article
Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1895, doi. 10.1002/cncr.34744
- By:
- Publication type:
- Article
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1885, doi. 10.1002/cncr.34742
- By:
- Publication type:
- Article
Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020).
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1930, doi. 10.1002/cncr.34734
- By:
- Publication type:
- Article
Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1919, doi. 10.1002/cncr.34733
- By:
- Publication type:
- Article
Top advances of the year: Breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1791, doi. 10.1002/cncr.34752
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1873, doi. 10.1002/cncr.34751
- By:
- Publication type:
- Article
Trying to outRun‐DIC in KMT2Ar AML: It's tricky.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1797, doi. 10.1002/cncr.34727
- By:
- Publication type:
- Article
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1856, doi. 10.1002/cncr.34728
- By:
- Publication type:
- Article
Bariatric surgery and oral chemotherapy: Where is the dosing guidance?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1800, doi. 10.1002/cncr.34721
- By:
- Publication type:
- Article
Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF‐mutant solid tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1904, doi. 10.1002/cncr.34730
- By:
- Publication type:
- Article
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1846, doi. 10.1002/cncr.34706
- By:
- Publication type:
- Article
Influence of depression on breast cancer treatment and survival: A Kentucky population‐based study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1821, doi. 10.1002/cncr.34676
- By:
- Publication type:
- Article
Association between bariatric surgery and outcomes in chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1866, doi. 10.1002/cncr.34725
- By:
- Publication type:
- Article
One fixed dosing of a poly(adenosine diphosphate ribose) polymerase inhibitor does not fit all.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1795, doi. 10.1002/cncr.34705
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1781, doi. 10.1002/cncr.33715
- Publication type:
- Article